Hot Promising Companies To Own For 2015

Merck (NYSE: MRK  ) is scheduled to release its quarterly earnings report tomorrow, and most investors expect the company to see continued reductions in its overall net income compared to year-ago levels. Yet the stock has performed quite well lately, suggesting that in the long run, Merck earnings could well return to their winning ways, helping to support a dividend yield that puts the drugmaker in the upper echelon of dividend stocks within the Dow Jones Industrials (DJINDICES: ^DJI  ) .

Like many of its drugmaker peers, Merck has struggled as major blockbuster products have gone off patent, forcing it to try to find replacement drugs to keep its overall sales and profit up. So far, Merck has only had mixed success in accomplishing that difficult task, but some promising prospects could help the company get past its patent-cliff woes and get back to strong growth. Let's take an early look at what's been happening with Merck over the past quarter and what we're likely to see in its quarterly report.

Hot India Companies To Watch For 2016: CC Media Holdings Inc (CCMO)

CC Media Holdings, Inc., incorporated May 2007, is a diversified media and entertainment company. The Company provides radio, digital, out-of-home, mobile and on-demand entertainment, and information services for audiences and local communities, and providing opportunities for advertisers. The Company operates in three segments: Media and Entertainment (CCME, formerly Radio), Americas outdoor advertising (Americas outdoor) and International outdoor advertising (International outdoor). On April 29, 2011, the Company acquired the traffic business of Westwood One, Inc. (the Traffic acquisition). The Company, during 2011, also purchased a cloud-based music technology business. During 2011, the Company also acquired Brouwer & Partners, a street furniture business. During 2011, the Company divested and exchanged its 27 radio stations.

CCME

The CCME segments operations include radio broadcasting, online and mobile services and products, program syndication, entertainment, traffic data distribution and music research services. The Company�� radio stations and content can be heard on amplitude modulation (AM) / frequency modulation (FM) stations, high definition (HD) radio stations, satellite radio, the Internet at iHeartRadio.com, and the Company�� radio stations Websites, through the Company�� iHeartRadio mobile application on iPads and smart phones, and via navigation systems. As of December 31, 2011, the Company owned 866 radio stations, including 249 AM and 617 FM servicing approximately 150 the United States markets.

The Company operates premiere networks (Premiere), a national radio network that produces, distributes or represents approximately 90 syndicated radio programs, and serves approximately 5,800 radio station affiliates. The Company�� syndicated radio programs include Rush Limbaugh, Jim Rome, Steve Harvey, Ryan Seacrest, Elvis Duran and Delilah. It also delivers real-time traffic information via navigation systems, radio and television broadcast m! edia and wireless and Internet-based services through the Company�� traffic business, total traffic network. During 2011, the CCME segment generated 48% of the Company�� revenues. The primary source of revenue in the CCME segment is the sale of commercials on the Company�� radio stations for local, regional and national advertising. The Company�� advertisers include consumer services, retailers, entertainment, health and beauty products, telecommunications, automotive and media.

Americas Outdoor Advertising

The Americas outdoor advertising segment operates in the markets of the United States, Canada and Latin America. It consists of billboards, street furniture and transit displays, airport displays, mall displays, and wall scapes, and other spectaculars, which the Company owns or operates under lease management agreements. As of December 31, 2011, the Company owned and operated approximately 125,000 display structures in its Americas outdoor advertising segment with operations in the United States. The Americas outdoor advertising segment generated 21% of the Company�� revenues during 2011. Americas outdoor revenue is derived from the sale of advertising copy placed on the Company�� digital displays and traditional displays. The Company�� display inventory consists primarily of billboards, street furniture displays and transit displays.

The street furniture displays of the Company include advertising surfaces on bus shelters, information kiosks, freestanding units and other public structures. The transit displays advertise on various types of vehicles or within transit systems, including on the interior and exterior sides of buses, trains, trams, and in the common areas of rail stations and airports. The other display inventories consist of spectaculars, wall scapes and mall displays.

International Outdoor Advertising

The International outdoor business segment includes the Company�� operations in Asia, Australia and E! urope, wi! th approximately 34% of its revenue in this segment derived from France and the United Kingdom during 2011. As of December 31, 2011, the Company owned or operated approximately 630,000 displays across 30 countries. The International outdoor segment generated 27% of the Company�� revenues during 2011. International outdoor advertising revenue is derived from the sale of traditional advertising copy placed on the Company�� display inventory and electronic displays, which are part of the Company�� network of digital displays. The International outdoor display inventory consists primarily of street furniture displays, billboards, transit displays and other out-of-home advertising displays, such as neon displays.

The Company competes with JCDecaux, CBS and Lamar Advertising Company.

Advisors' Opinion:

• [By CRWE]

  Last Friday, CCMO remained (0.00%) +0.000 at $4.90 at the close (ref. google finance August 9, 2013 ��Close).

  CC Media Holdings, Inc. previously reported financial results for the second quarter ended June 30, 2013.

  Revenue grew 1% to $1.6 billion, excluding foreign exchange and divestitures
  OIBDAN1 declined 5% year over year to $505 million, excluding foreign exchange and divestitures; OIBDAN margin of 31%
  Extended $5.0 billion of term loans to 2019 from 2016, and exchanged senior notes due 2016 for senior notes due 2021

• [By CRWE]

  Today, CCMO� remains (0.00%) +0.000 at $4.71 thus far (ref. google finance Delayed:�� 3:18PM EDT August 5, 2013).

  CC Media Holdings, Inc. previously reported financial results for the second quarter ended June 30, 2013.

  Revenue grew 1% to $1.6 billion, excluding foreign exchange and divestitures
  OIBDAN1 declined 5% year over year to $505 million, excluding foreign exchange and divestitures; OIBDAN margin of 31%
  Extended $5.0 billion of term loans to 2019 from 2016, and exchanged senior notes due 2016 for senior notes due 2021

• [By CRWE]

  Today, CCMO surged (+0.82%) up +0.05 at $6.15 with 8,240 shares in movement thus far (ref. google finance Delayed: 10:27AM EDT June 19, 2013).

  Clear Channel Media & Entertainment and Fleetwood Mac previously reported a landmark agreement ��the first direct performing rights partnership between a radio company and an artist ��that will enable the group to receive revenue from airplay on Clear Channel�� digital and broadcast radio platforms. The group�� new EP, Extended Play, features the first recording of new Fleetwood Mac music since the release of ��ay You Will��over a decade ago.

  ��leetwood Mac has consistently pushed the envelope ��creating new sounds, making music that seems designed for radio and looking at the industry in new ways,��said Irving Azoff of Azoff Music Management, a representative of the band. ��t�� fitting that a group that�� played such an integral role in radio and music history would be the first band to take such a major step — helping the music industry create a sustainable digital marketplace so it can thrive for decades to come. We��e delighted to join Clear Channel in creating a new model for the music industry, one that will be good for performing artists, good for music fans, and good for the people who have invested their talent, time and money.��/p>

Hot Promising Companies To Own For 2015: Immune Design Corp (IMDZ)

Immune Design Corp, incorporated on February 20, 2008, is a clinical-stage immunotherapy company. The Company has engineered its technologies to activate the immune system�� natural ability to create tumor-specific cytotoxic T cells (CTLs), to fight cancer. The Company is developing multiple product candidates from its two discovery platforms, DCVex and GLAAS. The Company�� product candidates, LV305, CMB305 and G100, utilize multiple immuno-oncology approaches. LV305 was developed from the DCVex platform and it is enrolling patients in a Phase I clinical trial for the treatment of five solid tumor types. CMB305 is a prime-boost approach that combines LV305 with a second agent, G305. G100 was developed from the GLAAS platform and it is enrolling patients with Merkel cell carcinoma in a Phase I clinical trial.

The Company�� immuno-oncology product candidates are being developed in two separate approaches: Specific Antigen and Endogenous Antigen. The Specific Antigen approach uses selected antigens that are also present in the patient�� tumor so that the immune system will be educated to recognize the tumor antigen and kill tumor cells expressing the antigen. The Endogenous Antigen approach, in contrast, does not require a selected antigen present in the tumor. It instead relies on treatments, such as chemotherapy or local radiation to lyse tumors and release endogenous antigens, which are then captured by neighboring GLAAS-activated dendritic cells, generating a varied immune response. The Company utilizes DCVex and GLAAS to develop product candidates that work in vivo and are designed to create and expand diverse armies of CTLs to fight tumors. DCVex is a discovery platform that uses a first-in-class vector to generate product candidates designed to create CTLs in vivo. The DCVex vector is a delivery system based on a re-engineered virus to carry the genetic information of a tumor antigen safely and selectively to dendritic cells (DCs), in the skin. The GLAAS platform also works in! vivo and is based on a small synthetic molecule called GLA, which stands for glucopyranosyl lipid A. GLA selectively binds to the TLR4 receptor and causes potent activation of the DC.

Advisors' Opinion:

• [By WWW.DAILYFINANCE.COM]

  www.gopro.com Now that it's nearly over, we can definitively say that 2014 has been one of the best years for initial public stock offerings in history. In terms of proceeds raised from IPOs, 2014 will challenge or even exceed the year 2000. Which is saying something: That was the height of the dot.com frenzy, when seemingly every new company with a website felt compelled to list on the stock exchange. As can be expected of a busy IPO year, some of 2014's new stock market titles have been runaway hits soaring above their issue price, while others have belly-flopped. Since we're heading into the most optimistic time of the year, we'll shine a light on the three best performers. In order of stock price appreciation, they are: GoPro (GPRO) 2014's current IPO front-runner is this company, maker of the popular action photography camera -- the one that's usually responsible for those hairy point-of-view videos posted on Facebook (FB) and other online sharing sites. GoPro's stock hit the market at the end of June priced at $24, and as if this writing it now stands at $70.72 for a muscular 195 percent total return. Although that's impressive, it should be noted that the current price is quite a bit lower than the stock's high of nearly $94, which it touched in early October. But then the camera was effectively blamed for the horrific accident that befell Formula One racing star Michael Schumacher -- although the journalist making the allegation later recanted -- and the shares cratered. The stock recovered after the company reported strong third-quarter earnings, and all seemed well again... until GoPro decided to float a secondary issue of stock. It'll sell 10.3 million fresh shares on the market, adding to the nearly 126 million currently outstanding. When secondary share issues are announced, a company's stock often takes a hit, since investors aren't too crazy about their existing stakes being diluted. Regardless, on a fundamental basis GoPro is a popular, if

Hot Promising Companies To Own For 2015: Peerless Systems Corporation(PRLS)

Peerless Systems Corporation holds the right to license imaging and networking technologies and components to the digital document markets. It licenses technologies and components for the original equipment manufacturers of color and monochrome printers, and multifunction office products. The company was founded in 1982 and is headquartered in Stamford, Connecticut.

Advisors' Opinion:

• [By Monica Gerson]

  Peerless Systems Corporation (NASDAQ: PRLS) agreed to be acquired by Mobius Acquisition, LLC for $7.00 per share in cash. Peerless Systems shares jumped 27.25% to $6.72 in the after-hours trading session.

Hot Promising Companies To Own For 2015: Halozyme Therapeutics Inc.(HALO)

Halozyme Therapeutics, Inc., a biopharmaceutical company, engages in the research, development, and commercialization of recombinant human enzymes that transiently modify tissue under the skin to facilitate injection of other therapies or correct diseased tissue structures for clinical benefits. The company primarily offers recombinant human hyaluronidase, an enzyme that degrades hyaluronan, which is a matrix component in the skin, and facilitates the dispersion and absorption of drugs and fluids. Its portfolio of products and product candidates are developed based principally on intellectual property covering the family of human enzymes known as hyaluronidases. The company also provides Ultrafast Insulin program, a Phase II clinical trial product for the treatment of diabetes mellitus; and Enhanze technology, a proprietary drug delivery platform for subcutaneous delivery of injectable biologics, such as monoclonal antibodies and other therapeutic molecules, as well as sma ll molecules and fluids. It offers PEGPH20, a new molecular entity that is in Phase I trial for the systemic treatment of tumors; and HTI-501, a recombinant human proteinase, which is in Phase 1/2 clinical trial used for the treatment of edematous fibrosclerotic panniculopathy (cellulite). The company has collaborative partnerships with F. Hoffmann-La Roche, Ltd and Hoffmann-La Roche, Inc.; ViroPharma Incorporated; and Intrexon Corporation to apply Enhanze technology to the partners? biological therapeutic compounds. Halozyme Therapeutics, Inc. was founded in 1998 and is based in San Diego, California.

Advisors' Opinion:

• [By Keith Speights]

  Halozyme Therapeutics (NASDAQ: HALO  ) isn't quite as close to commercialization. The company has a mid-stage study under way that combines its rHuPH20 hyaluronidase enzyme with a mealtime insulin analog. Halozyme's enzyme helps the insulin to be absorbed more quickly than it would normally.

• [By Jake L'Ecuyer]

  Halozyme Therapeutics (NASDAQ: HALO) was also down, falling 13.11 percent to $13.91 after the company's wider than expected loss disappointed the street Friday morning.

• [By Monica Gerson]

  Halozyme Therapeutics (NASDAQ: HALO) shares dropped 2.04% to $8.12 after the company reported a clinical hold of PEGPH20 pancreatic cancer trial amid voluntary halt.

Hot Promising Companies To Own For 2015: Mesabi Trust (MSB)

Mesabi Trust operates as a royalty trust in the United States. The company produces iron ore pellets. It holds interest in the Peter Mitchell mine located in the Mesabi Iron Range near Babbitt, Minnesota. The company holds various agreements with the Northshore Mining Company that mines iron ore, which is in the form of taconite, crushes it, separates the iron particles from the non-metallic, and forms the resulting concentrate into pellets that are shipped for use in steel-producing blast furnaces of customers of CCI, a mining company that produces iron pellets in North America. Mesabi Trust was founded in 1919 and is based in New York, New York.

Advisors' Opinion:

• [By Selena Maranjian]

  Patience, Grasshopper
  For starters, imagine that you invested in Mesabi Trust (NYSE: MSB  ) about a year ago and you're down some 20% on your investment. Your holding might be looking to you like an answer to the question, "What is investment panic, Alex?" But don't be so hasty. Ask yourself why you bought it. Mesabi Trust is a royalty trust that receives and then pays out to shareholders a portion of the proceeds from iron mined by a�Cliffs Natural Resources�subsidiary. Some might avoid it because royalty trusts often have expiration dates, but it's worth noting that Mesabi's is rather�far away. But slowdown in demand�for ore is a concern, one that has been�an issue for Cliffs, too.